TABLE 2.
Characteristic | Group 1 | Group 2 | P value |
---|---|---|---|
Age, mean ± SD | 48 ± 13 y | 50 ± 14 y | |
Sex | 51% male, 49% female | 59% male, 41% female | |
Emphysema | 52% | 25.8% | |
Cystic fibrosis | 18.2% | 17.7% | |
Pulmonary fibrosis | 16.1% | 46% | |
Pulmonary vascular disease | 7.2% | 1.6% | |
Double or single transplant | 77.7% double, 22.3% single | 96.2% double, 3.8% single | |
Primary graft dysfunction | 22.1% | 31.6% | <.001 |
Hospital mortality | 4.4% | 3.5% | <.4 |
1-y survival | 84.3% | 89.3% | <.02 |
Group 1 (before introduction of lung allocation score); Group 2 (after introduction of lung allocation score). Primary graft dysfunction (PGD) is defined as PGD grade 3 identified from the time of transplant to 72 hours post-transplant. SD, Standard deviation.